Clinical Trials Logo

Filter by:
NCT ID: NCT01392781 Recruiting - Clinical trials for Polycystic Ovary Syndrome

Markers and Calculation of Cardiovascular Risk in the Distinct Phenotypes of Polycystic Ovary Syndrome

Start date: April 2011
Phase: N/A
Study type: Observational

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder and cause of anovulatory infertility among reproductive aged women. According to the revised criteria of 2003, four distinct phenotypes of PCOS can be diagnosed. However, there are emerging evidence supporting the existence of different levels of cardiometabolic risk between the four phenotypic groups of the syndrome. The purpose of this study is to determine the cardiovascular risk of i) normoweight and ii)overweight plus obese women of every one of the four phenotypes of the syndrome as well as the levels of low inflammation serum markers and the possible correlations of the between the outcomes.

NCT ID: NCT01398449 Recruiting - Clinical trials for Esophageal Squamous Cell Carcinoma

Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0

Start date: April 2011
Phase: Phase 3
Study type: Interventional

Is elective nodal irradiation (ENI) necessary for patients with thoracic esophageal cancer after esophagectomy and with pathological stage of T1-2,N+,M0?

NCT ID: NCT01403506 Recruiting - Clinical trials for Disorder Related to Renal Transplantation

Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)

Start date: April 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the effect of (NAC) N-Acetyl Cysteine on biomarkers of Delayed Graft Function (DGF), including Neutrophil Gelatinase Associated Lipocalin (NGAL) and Intereleukin 18 (IL18).

NCT ID: NCT01410760 Recruiting - Clinical trials for Metastatic Colorectal Cancer

PERfusion CT in the FOXFIRE Trial to Study Blood Flow to Liver Metastases

PERFORM
Start date: April 2011
Phase: Phase 0
Study type: Interventional

The PERFORM study is a pilot study investigating the feasibility and usefulness of performing a novel CT (Computed Tomography)scanning technique called Perfusion CT(CTP) as an addition to normal CT scanning in patients recruited to the FOXFIRE trial. All patients recruited to FOXFIRE at the Oxford Radcliffe Hospitals and University Hospitals of Leicester will be invited to take part. FOXFIRE is a national randomised controlled trial in which patients with unresectable liver tumours secondary to colorectal cancer will receive treatment with standard chemotherapy alone, or with chemotherapy in combination with an internal radiotherapy treatment which delivers radioactive particles(SIR-spheres) to the liver via its own blood supply (radioembolisation). In the FOXFIRE study a normal CT scan would usually be performed prior to the start of treatment and also three months after the commencement of treatment to assess the cancer's response to treatment, particularly whether the tumour has changed in size as a result of treatment. Perfusion CT gives the normal information on changes in tumour size but also assesses whether the blood flow to the cancer has changed, which may allow earlier identification of treatment success compared to normal CT scans. All patients consenting to participate in the PERFORM study will undergo four perfusion CT scans: one before the treatment starts, and one at the start of each of the second, third and fifth cycles of chemotherapy. The aim is to determine the feasibility of measuring tumour perfusion for data analysis using perfusion CT and to establish if the tumour perfusion pattern at baseline or shortly after the start of therapy can predict response to radioembolisation or chemotherapy. This research is funded by the National Institute for Health Research Biomedical Research Centre in Oxford and Oxfordshire Health Services Research Committee.

NCT ID: NCT01411046 Recruiting - Clinical trials for Rheumatoid Arthritis

Difference in GC-induced Adrenal Insufficiency in RA Related to Polymorphisms in the Glucocorticoid Receptor Gene

Start date: April 2011
Phase: N/A
Study type: Observational

Development of glucocorticoid (GC)-induced adrenal insufficiency is a serious adverse effect of GC treatment. It is today not possible to predict this adverse effect. The project aims at investigating a possible individual aspect, which may render subjects more or less sensitive to glucocorticoids, and thereby influence development of GC induced adrenal insufficiency. The hypothesis is that subjects with one or another of the polymorphisms in the GC receptor gene will either have increased or diminished GC sensitivity. This may be responsible for differences in development of GC induced adrenal insufficiency.

NCT ID: NCT01415310 Recruiting - Depression Clinical Trials

Quality Register for Geriatric Psychiatry

KVALAP
Start date: April 2011
Phase:
Study type: Observational

QualGeP (KVALAP) is a quality register in Viken Research network for Geriatric Psychiatry. The objectives of the register are to enhance our knowledge of old persons with severe psychiatric disorders, and to secure an optimal medical evaluation, treatment and care for these patients. The data in the register will be used for quality assurance and for research. Aims: - Quality assurance - Further development of our diagnostic and screening tools - Contributing to improving the treatment, with and without drugs - Contributing to improving the dialogue and collaboration between primary healthcare and hospitals

NCT ID: NCT01425333 Recruiting - Endometriosis Clinical Trials

The Impact of Surgical Treatment of Endometriomas on Ovarian Reserve

Start date: April 2011
Phase: N/A
Study type: Interventional

The aim of this study is to assess which of two commonly used surgical procedures in the treatment of ovarian cysts called endometriomas (cutting out of the cyst - "cystectomy", or draining it and cauterising it's inner lining - "ablation") causes the least damage to the ovary and is therefore best at maintaining the future fertility potential of a patient.

NCT ID: NCT01426737 Recruiting - Type 2 Diabetes Clinical Trials

The Swiss Glucose Variability Study

Start date: April 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to explore long term glucose variability of a combination therapy of metformin and vildagliptin compared to a metformin - gliclazide combination. Multicenter, randomized, open, parallel group, Phase IV study, of 18 months duration. - Trial with medicinal product

NCT ID: NCT01430728 Recruiting - Clinical trials for Infant, Very Low Birth Weight

Cerebral Tissue Oxygenation in Very Low Birthweight Infants in the First 3 Days of Life

Start date: April 2011
Phase: N/A
Study type: Observational

The purpose of this study is to examine the range of cerebral tissue oxygen saturation in healthy and sick very low birthweight infants during the first 72 hours of life.

NCT ID: NCT01435057 Recruiting - Abdominal Obesity Clinical Trials

Effects of Different Exercise Training Regimens on Visceral Fat Dynamic and Resting Energy Expenditure in Obese Patients

Start date: April 2011
Phase: N/A
Study type: Interventional

In this project, the investigators will test the hypothesis that predominant (two to three times a week 60 min) strength training is more effective in reducing visceral fat mass than endurance training in obese patients.